UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

UBS maintains Cigna stock Buy rating with $390 target View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 42,615.50 ...

UBS maintains Cigna stock Buy rating with $390 target View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 41,598.50 ...

Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE ... If you are looking for an AI stock that is more promising than CI and that has a 100x upside ...

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

On Monday, Raymond (NSE: RYMD) James increased its price target on shares of CIGNA (NYSE: CI) to $385 from the previous target of $360, while reiterating a Strong Buy rating on the stock.With a market ...

On April 23, the company's board declared a cash dividend of $1.51 per share of its common stock. Cigna shares fell ... David Macdonald maintained a Buy rating and raised the price target from ...

With a market cap of $84.3 billion, The Cigna Group (CI) is a leading global health services company headquartered in Bloomfield, Connecticut, serving over 178 million customers in more than 30 ...